Gene · 474
Papers1,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging mechanisms progress of colorectal cancer liver metastasis. | Front Endocrinol (Lausanne) | 2022 | 36568117 | PubTator, text mining | PubMed |
| Multiprotein GLI Transcriptional Complexes as Therapeutic Targets in Cancer. | Life (Basel) | 2022 | 36556332 | PubTator, text mining | PubMed |
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Circulating Tumor DNA-A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques. | Cancers (Basel) | 2022 | 36551512 | PubTator, text mining | PubMed |
| Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. | Mol Cancer | 2022 | 36550571 | PubTator, text mining | PubMed |
| Valproic acid exposure decreases neurogenic potential of outer radial glia in human brain organoids. | Front Mol Neurosci | 2022 | 36523605 | PubTator, text mining | PubMed |
| Cellular reprogramming with ATOH1, GFI1, and POU4F3 implicate epigenetic changes and cell-cell signaling as obstacles to hair cell regeneration in mature mammals. | Elife | 2022 | 36445327 | PubTator, text mining | PubMed |
| Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes. | Cancers (Basel) | 2022 | 36428693 | PubTator, text mining | PubMed |
| Repurposing the lineage-determining transcription factor Atoh1 without redistributing its genomic binding sites. | Front Cell Dev Biol | 2022 | 36420143 | PubTator, text mining | PubMed |
| Phox2b mutation mediated by Atoh1 expression impaired respiratory rhythm and ventilatory responses to hypoxia and hypercapnia. | Elife | 2022 | 36394266 | PubTator, text mining | PubMed |
| Single-cell mechanistic studies of radiation-mediated bystander effects. | Front Immunol | 2022 | 36389749 | PubTator, text mining | PubMed |
| The plant stem-cell niche and pluripotency: 15 years of an epigenetic perspective. | Front Plant Sci | 2022 | 36388540 | PubTator, text mining | PubMed |
| Chromatin Accessibility and Transcriptional Differences in Human Stem Cell-Derived Early-Stage Retinal Organoids. | Cells | 2022 | 36359808 | PubTator, text mining | PubMed |
| A Strategy for Magnetic and Electric Stimulation to Enhance Proliferation and Differentiation of NPCs Seeded over PLA Electrospun Membranes. | Biomedicines | 2022 | 36359255 | PubTator, text mining | PubMed |
| The expression changes of transcription factors including ANKZF1, LEF1, CASZ1, and ATOH1 as a predictor of survival rate in colorectal cancer: a large-scale analysis. | Cancer Cell Int | 2022 | 36344988 | PubTator, text mining | PubMed |
| Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma. | Front Cell Dev Biol | 2022 | 36340043 | PubTator, text mining | PubMed |
| Contribution of TWIST1-EVX1 Axis in Invasiveness of Esophageal Squamous Cell Carcinoma; a Functional Study. | Iran J Biotechnol | 2022 | 36337061 | PubTator, text mining | PubMed |
| Modelling inner ear development and disease using pluripotent stem cells - a pathway to new therapeutic strategies. | Dis Model Mech | 2022 | 36331565 | PubTator, text mining | PubMed |
| Molecular regulation after mucosal injury and regeneration in ulcerative colitis. | Front Mol Biosci | 2022 | 36310594 | PubTator, text mining | PubMed |
| Current In Vitro and In Vivo Models to Study MCPyV-Associated MCC. | Viruses | 2022 | 36298759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/474/papers?page=13